These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 26215400

  • 1. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

  • 2. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M, Czajkowski K, Smolarczyk R.
    Scand J Gastroenterol; 2016 Jan 29; 51(1):78-85. PubMed ID: 26152830
    [Abstract] [Full Text] [Related]

  • 3. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct 29; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 4. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
    J Hepatol; 2021 May 29; 74(5):1087-1096. PubMed ID: 33276032
    [Abstract] [Full Text] [Related]

  • 5. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
    Zapata R, Sandoval L, Palma J, Hernández I, Ribalta J, Reyes H, Sedano M, Tohá D, Silva JJ.
    Liver Int; 2005 Jun 29; 25(3):548-54. PubMed ID: 15910492
    [Abstract] [Full Text] [Related]

  • 6. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B, Özler S.
    Hepatobiliary Pancreat Dis Int; 2020 Jun 29; 19(3):271-276. PubMed ID: 31919038
    [Abstract] [Full Text] [Related]

  • 7. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG.
    Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F, Zhang L, He MM, Liu ZF, Gao BX, Wang XD.
    Curr Med Res Opin; 2014 Aug 27; 30(8):1529-35. PubMed ID: 24665980
    [Abstract] [Full Text] [Related]

  • 9. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG, PITCHES study group.
    Lancet; 2019 Sep 07; 394(10201):849-860. PubMed ID: 31378395
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of obstetric cholestasis with polyunsaturated phosphatidylcholine and ursodeoxycholic acid].
    Marciniak B, Kimber-Trojnar Z, Leszczyńska-Gorzelak B, Patro-Małysza J, Trojnar M, Oleszczuk J.
    Ginekol Pol; 2011 Jan 07; 82(1):26-31. PubMed ID: 21473053
    [Abstract] [Full Text] [Related]

  • 11. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E.
    Hepatology; 2001 Mar 07; 33(3):504-8. PubMed ID: 11230728
    [Abstract] [Full Text] [Related]

  • 12. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A, Marschall HU, Lammert F, Mattsson LA.
    Hepatology; 2005 Dec 07; 42(6):1399-405. PubMed ID: 16317669
    [Abstract] [Full Text] [Related]

  • 13. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial.
    Fleminger J, Seed PT, Smith A, Juszczak E, Dixon PH, Chambers J, Dorling J, Williamson C, Thornton JG, Chappell LC.
    BJOG; 2021 May 07; 128(6):1066-1075. PubMed ID: 33063439
    [Abstract] [Full Text] [Related]

  • 14. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB, Ovadia C, Lövgren-Sandblom A, Chambers J, Begum S, Seed P, Walker I, Chappell LC, Marschall HU, Williamson C.
    BJOG; 2019 Dec 07; 126(13):1633-1640. PubMed ID: 31483939
    [Abstract] [Full Text] [Related]

  • 15. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A, Maciejewski T, Niemiec KT.
    Med Wieku Rozwoj; 2013 Dec 07; 17(3):232-45. PubMed ID: 24296447
    [Abstract] [Full Text] [Related]

  • 16. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR.
    Arch Dermatol; 2007 Jun 07; 143(6):757-62. PubMed ID: 17576942
    [Abstract] [Full Text] [Related]

  • 17. Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome.
    Hamud A, Cohen MJ, Hochner-Celnikier D, Bar-Oz B, Ackerman Z.
    Ann Hepatol; 2024 Jun 07; 29(3):101490. PubMed ID: 38403070
    [Abstract] [Full Text] [Related]

  • 18. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
    Kawakita T, Parikh LI, Ramsey PS, Huang CC, Zeymo A, Fernandez M, Smith S, Iqbal SN.
    Am J Obstet Gynecol; 2015 Oct 07; 213(4):570.e1-8. PubMed ID: 26071912
    [Abstract] [Full Text] [Related]

  • 19. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
    Geenes V, Lövgren-Sandblom A, Benthin L, Lawrance D, Chambers J, Gurung V, Thornton J, Chappell L, Khan E, Dixon P, Marschall HU, Williamson C.
    PLoS One; 2014 Oct 07; 9(1):e83828. PubMed ID: 24421907
    [Abstract] [Full Text] [Related]

  • 20. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
    Bacq Y, le Besco M, Lecuyer AI, Gendrot C, Potin J, Andres CR, Aubourg A.
    Dig Liver Dis; 2017 Jan 07; 49(1):63-69. PubMed ID: 27825922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.